Am J Respir Crit Care Med

1. GONZALEZ AV, Silvestri GA, Korevaar DA, Gesthalter YB, et al
   Assessment of Advanced Diagnostic Bronchoscopy Outcomes for Peripheral Lung Lesions: A Delphi Consensus Definition of Diagnostic Yield and Recommendations for Patient-centered Study Designs. An Official American Thoracic Society/American College of Ch
   Am J Respir Crit Care Med. 2024;209:634-646.
   

   >> Share

   
   

   
   Ann Surg Oncol

2. GRENDA TR
   Refocusing the Prognosis Lens: Conditional Survival After Surgery in Limited-Stage Small Cell Lung Cancer.
   Ann Surg Oncol. 2024 Mar 21. doi: 10.1245/s10434-024-15168.
   

   >> Share

   
   

   
   Ann Thorac Surg

3. TOWE CW, Grau-Sepulveda MV, Hartwig MG, Kang L, et al
   STS Database Analysis: Comparing Sublobar Techniques in Stage IA Lung Cancer.
   Ann Thorac Surg. 2024 Mar 15:S0003-4975(24)00191.
   

   >> Share

   
   
4. FERRARIS VA
   Venous Thromboembolism as Postoperative Complication Following Lung Cancer Operations.
   Ann Thorac Surg. 2024 Mar 15:S0003-4975(24)00188.
   

   >> Share

   
   

   
   Br J Cancer

5. BARANYI M, Molnar E, Hegedus L, Gabriel Z, et al
   Farnesyl-transferase inhibitors show synergistic anticancer effects in combination with novel KRAS-G12C inhibitors.
   Br J Cancer. 2024;130:1059-1072.
   

   >> Share

   
   
6. REN Z, Dharmaratne M, Liang H, Benard O, et al
   Redox signalling regulates breast cancer metastasis via phenotypic and metabolic reprogramming due to p63 activation by HIF1alpha.
   Br J Cancer. 2024 Jan 18. doi: 10.1038/s41416-023-02522.
   

   >> Share

   
   
7. GORGULHO J, Roderburg C, Beier F, Bokemeyer C, et al
   Soluble lymphocyte activation gene-3 (sLAG3) and CD4/CD8 ratio dynamics as predictive biomarkers in patients undergoing immune checkpoint blockade for solid malignancies.
   Br J Cancer. 2024;130:1013-1022.
   

   >> Share

   
   

   
   Cancer

8. WISNIVESKY JP, Mudd J, Stone K, Slatore CG, et al
   Longitudinal quality of life after sublobar resection and stereotactic body radiation therapy for early-stage non-small cell lung cancer.
   Cancer. 2024 Mar 21. doi: 10.1002/cncr.35286.
   

   >> Share

   
   
9. AJABNOOR AM, Parisi R, Zghebi SS, Ashcroft DM, et al
   Oral anticoagulant prescribing among patients with cancer and atrial fibrillation in England, 2009-2019.
   Cancer. 2024;130:1316-1329.
   

   >> Share

   
   

   
   Cancer Res

10. GAI X, Liu Y, Lan X, Chen L, et al
    Oncogenic KRAS induces arginine auxotrophy and confers a therapeutic vulnerability to SLC7A1 inhibition in non-small cell lung cancer.
    Cancer Res. 2024 Mar 19. doi: 10.1158/0008-5472.CAN-23-2095.
    

    >> Share

    
    
11. MU M, Huang CX, Qu C, Li PL, et al
    Targeting ferroptosis-elicited inflammation suppresses hepatocellular carcinoma metastasis and enhances sorafenib efficacy.
    Cancer Res. 2024 Jan 17. doi: 10.1158/0008-5472.CAN-23-1796.
    

    >> Share

    
    

    
    Cancer Sci

12. 
    Correction to: Phytochemical library screening reveals betulinic acid as a novel Skp2-SCF E3 ligase inhibitor in non-small cell lung cancer.
    Cancer Sci. 2024 Mar 20. doi: 10.1111/cas.16163.
    

    >> Share

    
    

    
    Eur J Cancer

13. LEONETTI A, Perrone F, Puntoni M, Maglietta G, et al
    Real-world outcomes of Italian patients with advanced non-squamous lung cancer treated with first-line pembrolizumab plus platinum-pemetrexed.
    Eur J Cancer. 2024;202:114006.
    

    >> Share

    
    

    
    Int J Radiat Oncol Biol Phys

14. LIU YC, Schmidt RO, Kapadia NS, Phillips JD, et al
    Disparities in access to multidisciplinary cancer consultations and treatment for early-stage non-small cell lung cancer patients: A SEER-Medicare analysis.
    Int J Radiat Oncol Biol Phys. 2024 Mar 13:S0360-3016(24)00426.
    

    >> Share

    
    
15. VITZTHUM LK, Surucu M, Gensheimer MF, Kovalchuk N, et al
    BIOGUIDE-X: A First-in-Human Study of the Performance of Positron Emission Tomography-Guided Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2024;118:1172-1180.
    

    >> Share

    
    
16. VAIOS EJ, Shenker RF, Hendrickson PG, Wan Z, et al
    Long-term Intracranial Outcomes with Combination Dual Immune-Checkpoint Blockade and SRS in Patients with Melanoma and NSCLC Brain Metastases.
    Int J Radiat Oncol Biol Phys. 2023 Dec 12:S0360-3016(23)08234.
    

    >> Share

    
    

    
    J Cancer Res Clin Oncol

17. GE Y, Zhan Y, He J, Li J, et al
    PD-(L)1 inhibitors plus bevacizumab and chemotherapy as first-line therapy in PD-L1-negative metastatic lung adenocarcinoma: a real-world data.
    J Cancer Res Clin Oncol. 2024;150:135.
    

    >> Share

    
    
18. BANAT M, Potthoff AL, Hamed M, Borger V, et al
    Synchronous versus metachronous spinal metastasis: a comparative study of survival outcomes following neurosurgical treatment.
    J Cancer Res Clin Oncol. 2024;150:136.
    

    >> Share

    
    

    
    J Clin Invest

19. PEYVANDI S, Bulliard M, Yilmaz A, Kauzlaric A, et al
    Tumor-educated Gr1+CD11b+ cells drive breast cancer metastasis via OSM/IL6-JAK-induced cancer cell plasticity.
    J Clin Invest. 2024 Jan 18:e166847. doi: 10.1172/JCI166847.
    

    >> Share

    
    

    
    J Comput Assist Tomogr

20. HU Y, Geng Y, Wang H, Chen H, et al
    Improved Prediction of Epidermal Growth Factor Receptor Status by Combined Radiomics of Primary Nonsmall-Cell Lung Cancer and Distant Metastasis.
    J Comput Assist Tomogr. 2024 Mar 18. doi: 10.1097/RCT.0000000000001591.
    

    >> Share

    
    

    
    J Natl Cancer Inst

21. FUCITO LM, Palmer AM, Baldassarri SR
    A new perspective on mitigating lung cancer risks through smoking cessation and reduction.
    J Natl Cancer Inst. 2024 Mar 18:djae044. doi: 10.1093.
    

    >> Share

    
    

    
    J Thorac Cardiovasc Surg

22. RUSCH VW
    Commentary: "Real world" neoadjuvant immunochemotherapy for lung cancer:Additional data but still many questions.
    J Thorac Cardiovasc Surg. 2024 Mar 14:S0022-5223(24)00209.
    

    >> Share

    
    

    
    J Thorac Oncol

23. TRAVIS WD, Eisele M, Nishimura KK, Aly R, et al
    The IASLC Lung Cancer Staging Project: Recommendation to Introduce Spread Through Air Spaces (STAS) as a Histologic Descriptor in the 9(th) Edition of the TNM Classification of Lung Cancer.Analysis of 4,061 Pathologic Stage I Non-Small cell Lung Carci
    J Thorac Oncol. 2024 Mar 18:S1556-0864(24)00122.
    

    >> Share

    
    
24. BORGEAUD M, Parikh K, Banna GL, Kim F, et al
    Unveiling the Landscape of uncommon EGFR Mutations in Non-Small Cell Lung Cancer - A Systematic Review.
    J Thorac Oncol. 2024 Mar 16:S1556-0864(24)00123.
    

    >> Share

    
    

    
    JAMA Oncol

25. KEREKES DM, Frey AE, Prsic EH, Tran TT, et al
    Immunotherapy Initiation at the End of Life in Patients With Metastatic Cancer in the US.
    JAMA Oncol. 2024;10:342-351.
    

    >> Share

    
    

    
    Lung Cancer

26. WALLACE ND, Alexander M, Xie J, Ball D, et al
    The impact of pre-treatment smoking status on survival after chemoradiotherapy for locally advanced non-small-cell lung cancer.
    Lung Cancer. 2024;190:107531.
    

    >> Share

    
    

    
    PLoS One

27. ZHANG L, Xu L, Chen Z, You H, et al
    Risk factors and related miRNA phenotypes of chronic pain after thoracoscopic surgery in lung adenocarcinoma patients.
    PLoS One. 2024;19:e0297742.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

28. HAN X, Wang D, Yang L, Wang N, et al
    Activation of polyamine catabolism promotes glutamine metabolism and creates a targetable vulnerability in lung cancer.
    Proc Natl Acad Sci U S A. 2024;121:e2319429121.
    

    >> Share

    
    

    
    Thorax

29. JACOBS C
    Decoding pulmonary nodules: can machine learning enhance malignancy risk stratification?
    Thorax. 2024;79:293-294.
    

    >> Share

    
    
30. WARKENTIN MT, Al-Sawaihey H, Lam S, Liu G, et al
    Radiomics analysis to predict pulmonary nodule malignancy using machine learning approaches.
    Thorax. 2024;79:307-315.
    

    >> Share

    
    
31. ROSTOCK L, Holotiuk O, Ploenes T
    Well-differentiated papillary mesothelial tumour: a rare finding on the pleura.
    Thorax. 2024;79:380-381.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share